PBYI
Puma Biotechnology, Inc.
A biopharmaceutical company based in Los Angeles that develops and sells cancer treatments, best known for its breast-cancer drug Nerlynx, a pill given to adults with HER2-positive breast cancer to help stop the disease from returning. It was founded in 2010 by Alan Auerbach, the same entrepreneur behind the earlier Cougar Biotechnology, whose big-cat naming theme it kept: puma and cougar are simply two names for the same mountain lion, and the drug itself was licensed from Pfizer in 2011.
CUSIP: 74587V107HealthcareUS1 holder
Total Value
$79.2K
Total Shares
13.3K
Net Share Change
-785
Activity
1 selling
Investor
Value
Shares
Weight
Change
